Dr. Jeff Lombardo, PharmD, BCOP, Research Assistant Professor, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo
discusses chemotherapy compounding, related safety issues, and the advantages of INFUGEM™ (gemcitabine hydrochloride in 0.9% sodium chloride injection).
Associate Director
Empire State Patient Safety Assurance Network
Center for Integrated Global Biomedical Sciences
Research Assistant Professor
School of Pharmacy and Pharmaceutical Sciences
University at Buffalo
Buffalo, New York
Related Items
JHOP - April 2023 Vol 13, No 2 published on April 25, 2023 in Practical Issues in Pharmacy Management
JHOP - February 2022 Vol 12, No 1 published on March 1, 2022 in Original Article, Chemotherapy, Practical Issues in Pharmacy Management